Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Chemical Communications (Cambridge, England)|December 17, 2008
Simultaneous and cooperative gas storage and gas production using bifunctional zeolitesAstrid-Karla Boes, Paul S Wheatley, Bo Xiao, et al.
Journal of Inflammation (London, England)|September 1, 2022
SILAC-based quantitative proteomics to investigate the eicosanoid associated inflammatory response in activated macrophagesNicole Brace, Ian L Megson, Adriano G Rossi, et al.
Biochemical and Biophysical Research Communications|September 28, 2005
Sildenafil potentiates nitric oxide mediated inhibition of human platelet aggregationIngibjörg J Gudmundsdóttir, Sarah J McRobbie, Simon D Robinson, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 30, 2009
No association between the PPARG gene and schizophrenia in a British populationAditi Mathur, Matthew H Law, Tayebeh Hamzehloei, et al.
British Journal of Pharmacology|May 17, 2006
Mechanism of action of novel NO-releasing furoxan derivatives of aspirin in human plateletsCatriona M Turnbull, Clara Cena, Roberta Fruttero, et al.
Frontiers in Cardiovascular Medicine|December 15, 2015
Antioxidants in Cardiovascular Therapy: Panacea or False Hope?Katarzyna Goszcz, Sherine J Deakin, Garry G Duthie, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 19, 2008
The TGM2 gene is associated with schizophrenia in a British populationMatilda Bradford, Matthew H Law, Andrew D Stewart, et al.
Therapeutic Advances in Drug Safety|April 1, 2026
Treating hearts and minds: adverse cardiovascular effects of psychiatric medicationsAsdaq Shabbir Raja, Stephen J Leslie, Elizabeth Buist, et al.
Free Radical Biology & Medicine|February 26, 2022
Exercise decreases PP2A-specific reversible thiol oxidation in human erythrocytes: Implications for redox biomarkersDavid J Muggeridge, Daniel R Crabtree, Ahmet Tuncay, et al.
Cardiovascular Diabetology|May 24, 2011
Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetesKyle R Gibson, Tim J Winterburn, Fiona Barrett, et al.
Pageof 11